Great Point Partners as of Sept. 30, 2019
Portfolio Holdings for Great Point Partners
Great Point Partners holds 36 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Iovance Biotherapeutics (IOVA) | 9.1 | $99M | 5.5M | 18.20 | |
| Zogenix | 8.3 | $90M | 2.3M | 40.04 | |
| ACADIA Pharmaceuticals (ACAD) | 7.2 | $79M | 2.2M | 35.99 | |
| Audentes Therapeutics | 6.4 | $70M | 2.5M | 28.09 | |
| Ptc Therapeutics I (PTCT) | 6.2 | $68M | 2.0M | 33.82 | |
| Ascendis Pharma As Sponsored Adr (ASND) | 6.2 | $67M | 700k | 96.32 | |
| Zymeworks | 5.6 | $61M | 2.5M | 24.80 | |
| Mirati Therapeutics | 5.5 | $60M | 775k | 77.91 | |
| Acceleron Pharma | 5.3 | $58M | 1.5M | 39.51 | |
| Medicines Company Call Option | 4.6 | $50M | 1.0M | 50.00 | |
| Kura Oncology (KURA) | 4.3 | $47M | 3.1M | 15.17 | |
| Penumbra (PEN) | 3.7 | $40M | 300k | 134.49 | |
| Nektar Therapeutics (NKTR) | 3.6 | $39M | 2.1M | 18.22 | |
| United Therapeutics Corporation (UTHR) | 3.4 | $38M | 470k | 79.75 | |
| Dex (DXCM) | 2.1 | $23M | 151k | 149.24 | |
| Retrophin | 1.9 | $20M | 1.7M | 11.59 | |
| Tricida | 1.7 | $18M | 587k | 30.87 | |
| Dermira | 1.5 | $17M | 2.6M | 6.39 | |
| Prothena (PRTA) | 1.5 | $16M | 2.1M | 7.84 | |
| Ionis Pharmaceuticals (IONS) | 1.5 | $16M | 270k | 59.91 | |
| Tandem Diabetes Care (TNDM) | 1.4 | $15M | 250k | 58.98 | |
| Momenta Pharmaceuticals | 1.2 | $13M | 1.0M | 12.96 | |
| Genfit S A ads (GNFT) | 1.1 | $12M | 686k | 17.41 | |
| Allakos (ALLK) | 0.9 | $9.8M | 125k | 78.63 | |
| Silk Road Medical Inc Common (SILK) | 0.9 | $9.8M | 302k | 32.53 | |
| Millendo Therapeutics | 0.8 | $9.2M | 1.3M | 7.11 | |
| Turning Point Therapeutics I | 0.8 | $8.4M | 222k | 37.60 | |
| Menlo Therapeutics | 0.7 | $7.4M | 1.7M | 4.48 | |
| Abeona Therapeutics | 0.7 | $7.3M | 3.2M | 2.26 | |
| Atara Biotherapeutics (ATRA) | 0.6 | $7.1M | 500k | 14.12 | |
| Exelixis (EXEL) | 0.5 | $5.5M | 310k | 17.68 | |
| Axsome Therapeutics Call Option (AXSM) | 0.4 | $4.0M | 200k | 20.24 | |
| Proteostasis Therapeutics In | 0.3 | $3.0M | 3.5M | 0.85 | |
| Myovant Sciences | 0.2 | $1.7M | 325k | 5.20 | |
| Opko Health (OPK) | 0.0 | $193k | 92k | 2.09 | |
| Streamline Health Solutions (STRM) | 0.0 | $141k | 130k | 1.08 |
